MedTrace Logo

Bioequivalence of Ethylenediamine Dihydrochloride Study

NCT01798589 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2023-07-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the allergen ethylenediamine dihydrochloride when prepared using methylcellulose versus preparation using polyvinylpyrrolidone.

Conditions

  • Allergic Contact Dermatitis

Interventions

DRUG

Ethylenediamine dihydrochloride allergen patch

1 allergen panel containing 2 allergen and 2 control patches

Sponsors & Collaborators

  • Allerderm

    lead INDUSTRY

Principal Investigators

  • Joseph Fowler, MD · Dermatology Specialists

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01798589 on ClinicalTrials.gov